Drug-Drug Interaction Potential of Mavorixafor

NCT06914869 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Mavorixafor
DRUG: Carbamazepine
DRUG: Efavirenz

Sponsor

X4 Pharmaceuticals